Feature

Perimeter’s positive topline results signal potential for wide-spread user adoption of next-gen, ultra-high-res, AI-driven imaging tool during breast cancer surgeries

Perimeter Medical Imaging AI (TSX-V:PINK; OTC:PYNKF) is poised to transform cancer surgery, as positive topline results from a pivotal study designed to support the company’s planned FDA premarket approval (PMA)...

December 3, 2024

Feature

Clearmind spearheading novel, life-changing psychedelic solutions for binge behaviors and mental health

Clearmind Medicine (NASDAQ:CMND; FSE:CWY0) is discovering and developing safe, novel psychedelic-derived therapeutic candidates with its new psychoactive molecule, 5-Methoxy-2-aminoindane (MEAI), to address widespread...

November 26, 2024

Feature

Spectral combining diagnostics with targeted therapy in novel approach to septic shock

Spectral Medical (TSX: EDT) is seeking to improve outcomes for millions of patients with life-threatening endotoxic septic shock (ESS), by combining its targeted diagnostic, Endotoxin Activity Assay (EAA), with its...

November 12, 2024

Feature

Conavi’s recent RTO fuels trajectory of world’s first and only hybrid intravascular imaging system combining co-registered IVUS + OCT

Conavi Medical (TSXV:CNVI) is leveraging its recent reverse merger (RTO) with Titan Medical to accelerate the wide-spread adoption of its breakthrough imaging platform, the next-generation Novasight Hybrid System...

November 5, 2024

NEWS

Just a few of the companies we’ve highlighted along the way

Giving healthcare companies and their stories the exposure they deserve.

Perimeter’s positive topline results signal potential for wide-spread user adoption of next-gen, ultra-high-res, AI-driven imaging tool during breast cancer surgeries

Clearmind spearheading novel, life-changing psychedelic solutions for binge behaviors and mental health

Spectral combining diagnostics with targeted therapy in novel approach to septic shock

Conavi’s recent RTO fuels trajectory of world’s first and only hybrid intravascular imaging system combining co-registered IVUS + OCT

NEWS

Medicus enters agreement with Swanielle to expand Phase 2 trial in APAC

FDA accepts Revelation’s IND for Gemini in CKD

Elite launches generic hydrocodone and acetaminophen tables for pain management

Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy

CervoMed’s stock rises as FDA grants ODD to neflamapimod for dementia

Perimeter showcases ASBrS webinar focused on margin assessment using OCT during breast cancer surgery

Profound Medical to unveil 3rd TULSA-AI module, ‘UA Alignment Assistant’, at upcoming medical meetings

MaaT meets Phase 1b primary endpoint for Maat003 in ALS

IMUNON reports outcome of end-of-Phase 2 FDA meeting for IMNN-001 in ovarian cancer

Just a few of the companies we’ve highlighted along the way

General

More